Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
Not yet recruiting · NCT07556120 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG) | Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Not yet recruiting | Phase 1 | 2026-08-12 | NCT07556120 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of University of Science and Technology of China | Hefei | China | 5 |